Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antibodies; Anti-D”

23 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 23 results

Not applicableUnknownNCT04339127
What this trial is testing

Autoimmune Encephalitis With Anti-NMDA Receptor Antibodies Following Herpetic Encephalitis

Who this might be right for
Autoimmune EncephalitisAnti NMDA Receptor EncephalitisHerpetic Encephalitis
Hospices Civils de Lyon 12
Testing effectiveness (Phase 2)Looking for participantsNCT03274375
What this trial is testing

Immunoadsorption Therapy in Managing NMDAR Antibodies Encephalitis

Who this might be right for
Anti-NMDAR Encephalitis
Assistance Publique - Hôpitaux de Paris 20
Not applicableStudy completedNCT03297671
What this trial is testing

The Prevention of Rh Disease of Newborns in Pakistan

Who this might be right for
Rhesus DiseaseAnti-D (Rh) Antibodies Affecting Care of Mother
Aga Khan University 1,654
Testing effectiveness (Phase 2)Study completedNCT02163577
What this trial is testing

Study of KRN23 (Burosumab), a Recombinant Fully Human Monoclonal Antibody Against Fibroblast Growth Factor 23 (FGF23), in Pediatric Subjects With X-linked Hypophosphatemia (XLH)

Who this might be right for
X-linked Hypophosphatemia
Kyowa Kirin, Inc. 52
Large-scale testing (Phase 3)Study completedNCT04695860
What this trial is testing

Anti-FGF23 (Burosumab) in Adult Patients With XLH

Who this might be right for
X-linked Hypophosphatemia
Wuerzburg University Hospital 36
Post-approval studies (Phase 4)Study completedNCT04842032
What this trial is testing

Study to Assess the Safety, Pharmacokinetics and Efficacy of KRN23 in Pediatric Chinese Patients With XLH

Who this might be right for
X-linked Hypophosphatemia (XLH)
Kyowa Kirin Co., Ltd. 28
Not applicableUnknownNCT06183788
What this trial is testing

Antibody-mediated NMDA Receptor Encephalitis: Symptoms, Biomarkers, and Mechanisms of the Prolonged Recovery Stage

Who this might be right for
Anti-NMDA Receptor Encephalitis
Fundacion Clinic per a la Recerca Biomédica 20
Not applicableUnknownNCT05738668
What this trial is testing

Clinical-immunological Features of Anti-NMDAR Encephalitis

Who this might be right for
Anti NMDA Receptor Encephalitis
Hospices Civils de Lyon 400
Testing effectiveness (Phase 2)UnknownNCT02886897
What this trial is testing

Combinations of D-CIK Immunotherapy And Anti-PD-1 In Refractory Solid Tumors

Who this might be right for
Hepatocellular CarcinomaRenal Cell CarcinomaBladder Cancer+3 more
Sun Yat-sen University 50
Testing effectiveness (Phase 2)Looking for participantsNCT07093333
What this trial is testing

A Study in Participants With Anti-NMDAR Encephalitis and Anti-NMDAR Autoantibody-Associated Psychiatric Disease

Who this might be right for
Anti-N-methyl-D-aspartate Receptor (NMDAR) Encephalitis (ANRE)Anti-N-methyl-D-aspartate Receptor (NMDAR) Antibody-associated Psychiatric DiseaseAutoimmune Encephalitis
Arialys Australia Pty Ltd 30
Not applicableLooking for participantsNCT05017142
What this trial is testing

Swiss Pediatric Inflammatory Brain Disease Registry (Swiss-Ped-IBrainD)

Who this might be right for
Optic NeuritisTransverse MyelitisAcute Disseminated Encephalomyelitis+15 more
University of Bern 500
Very early researchStudy completedNCT04156906
What this trial is testing

RHD Genotype Matched Red Cells for Anti-D

Who this might be right for
Sickle Cell DiseaseAnti-D Antibodies
Children's Hospital of Philadelphia 5
Early research (Phase 1)Study completedNCT00877110
What this trial is testing

Anti-GD2 3F8 Antibody and Allogeneic Natural Killer Cells for High-Risk Neuroblastoma

Who this might be right for
NeuroblastomaBone Marrow, Sympathetic Nervous System
Memorial Sloan Kettering Cancer Center 71
Large-scale testing (Phase 3)Ended earlyNCT04981717
What this trial is testing

Examine the Efficacy and Safety of Anti-Fel d 1 Antibodies Injections in Cat-allergic Adolescent and Adult Patients With Allergic Rhinitis Who Live With a Cat

Who this might be right for
Allergic Rhinitis Due to Cat Allergy
Regeneron Pharmaceuticals 446
Large-scale testing (Phase 3)Study completedNCT01604343
What this trial is testing

CNTO 136 (Sirukumab), Administered Subcutaneously, in Patients With Active Rheumatoid Arthritis Despite Disease-Modifying Antirheumatic Drug (DMARD) Therapy (SIRROUND-D)

Who this might be right for
Arthritis, Rheumatoid
Janssen Research & Development, LLC 1,670
Testing effectiveness (Phase 2)Looking for participantsNCT07455851
What this trial is testing

A Trial to Study if REGN17372 in Combination With Linvoseltamab is Tolerable for Adult Participants With Relapsed/Refractory Multiple Myeloma

Who this might be right for
Relapsed Refractory Multiple Myeloma (RRMM)
Regeneron Pharmaceuticals 150
Large-scale testing (Phase 3)Study completedNCT03920072
What this trial is testing

Study of the Anti-FGF23 Antibody, Burosumab, in Adults With XLH

Who this might be right for
X-linked Hypophosphatemia
Kyowa Kirin Pharmaceutical Development Ltd 35
Not applicableUnknownNCT05394623
What this trial is testing

Prevalence and Burden of Hepatitis D Virus Infection in China Through Preoperative Examination Test (Predict Study)

Who this might be right for
Hepatitis DHepatitis BAntibodies; Anti-D+1 more
The First Affiliated Hospital with Nanjing Medical University 5,000
Post-approval studies (Phase 4)Study completedNCT04842019
What this trial is testing

Study to Assess the Safety, Pharmacokinetics and Efficacy of KRN23 in Adult Chinese Patients With XLH

Who this might be right for
X-linked Hypophosphatemia (XLH)
Kyowa Kirin Co., Ltd. 18
Post-approval studies (Phase 4)Study completedNCT01821911
What this trial is testing

The Post-Marketing Safety and Immunogenicity Research of Speeda® Rabies Vaccine for Human Use

Who this might be right for
Rabies Vaccine AllergyVaccination Adverse EventAnti-D Antibodies
Beijing Center for Disease Control and Prevention 10,500
Load More Results